APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Selected research

Market Structure

Global Enoxaparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025192 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Enoxaparin sodium is an anticoagulant medication (blood thinner).It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery. It is also used in those with acute coronary syndrome (ACS) and heart attacks. It is given by injection just under the skin or into a vein.It is also used during hemodialysis.

Europe is the largest market of Enoxaparin Sodium, with about 60% market share, followed by North America with about 17% market share. Currently, there are many players in this market.Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi, Rovi, Amphastar, Nanjing King-friend, Sandoz and some others are playing important roles in Enoxaparin sodium injection industry. Sanofi, Teva, Techdow (Hepalink), Fresenius Kabi and Rovi are the top 5 players of Enoxaparin Sodium, with about 85% market shares.

There are nine different dosage form of Enoxaparin Sodium. The market can be segmented into 20 mg/0.2mL, 30 mg/0.3mL, 40 mg/0.4mL, 60 mg/0.6mL, 80 mg/0.8mL, 100 mg/1mL, 120 mg/0.8mL, 150 mg/1mL, 300mg/3mL. 40 mg/0.4mL is almost the only used and efficient types and took 40% market share. By application, Hospital is the largest consumer group, with market share of 63%.

Read the full market overview

This report provides an overview of the global Enoxaparin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enoxaparin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enoxaparin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enoxaparin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Enoxaparin Sodium Segment by Company

Sanofi

Teva

Techdow (Hepalink)

Fresenius Kabi

Rovi

Amphastar

Nanjing King-friend

Sandoz

Apotex

Hangzhou Jiuyuan Gene Engineering

Cipla

Taj Pharma

Chengdu Baiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Changzhou Qianhong Bio-pharma

Hebei Changshan Biochemical Pharmaceutical

Beijing SL Pharmaceutical

Huadong Medicine

Bharat Serums

INTAS

LUPIN

Troikaa Pharmaceuticals

Aristopharma

Fosun Pharma

SciencePharma

PISA

Enoxaparin Sodium Segment by Type

20 mg/0.2mL

30 mg/0.3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

300mg/3mL

Enoxaparin Sodium Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enoxaparin Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Enoxaparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Enoxaparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Enoxaparin Sodium Industry Trends Table 2. Enoxaparin Sodium Industry Drivers Table 3. Enoxaparin Sodium Industry Opportunities and Challenges Table 4. Enoxaparin Sodium Industry Restraints Table 5. Global Enoxaparin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Enoxaparin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Enoxaparin Sodium Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Enoxaparin Sodium Sales Market Share by Manufacturers Table 9. Global Enoxaparin Sodium Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Enoxaparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Enoxaparin Sodium Manufacturers, Product Type & Application Table 13. Global Enoxaparin Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Enoxaparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 20 mg/0.2mL Table 17. Major Manufacturers of 30 mg/0.3mL Table 18. Major Manufacturers of 40 mg/0.4mL Table 19. Major Manufacturers of 60 mg/0.6mL Table 20. Major Manufacturers of 80 mg/0.8mL Table 21. Major Manufacturers of 100 mg/1mL Table 22. Major Manufacturers of 120 mg/0.8mL Table 23. Major Manufacturers of 150 mg/1mL Table 24. Major Manufacturers of 300mg/3mL Table 25. Global Enoxaparin Sodium Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 26. Global Enoxaparin Sodium Sales by Type (2021-2026) & (M Units) Table 27. Global Enoxaparin Sodium Sales by Type (2027-2032) & (M Units) Table 28. Global Enoxaparin Sodium Sales Market Share by Type (2021-2026) Table 29. Global Enoxaparin Sodium Sales Market Share by Type (2027-2032) Table 30. Global Enoxaparin Sodium Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 31. Global Enoxaparin Sodium Revenue by Type (2021-2026) & (M Units) Table 32. Global Enoxaparin Sodium Revenue by Type (2027-2032) & (M Units) Table 33. Global Enoxaparin Sodium Revenue Market Share by Type (2021-2026) Table 34. Global Enoxaparin Sodium Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Hospital Table 36. Major Manufacturers of Clinic Table 37. Major Manufacturers of Others Table 38. Global Enoxaparin Sodium Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 39. Global Enoxaparin Sodium Sales by Application (2021-2026) & (M Units) Table 40. Global Enoxaparin Sodium Sales by Application (2027-2032) & (M Units) Table 41. Global Enoxaparin Sodium Sales Market Share by Application (2021-2026) Table 42. Global Enoxaparin Sodium Sales Market Share by Application (2027-2032) Table 43. Global Enoxaparin Sodium Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 44. Global Enoxaparin Sodium Revenue by Application (2021-2026) & (M Units) Table 45. Global Enoxaparin Sodium Revenue by Application (2027-2032) & (M Units) Table 46. Global Enoxaparin Sodium Revenue Market Share by Application (2021-2026) Table 47. Global Enoxaparin Sodium Revenue Market Share by Application (2027-2032) Table 48. Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 49. Global Enoxaparin Sodium Sales by Region (2021-2026) & (M Units) Table 50. Global Enoxaparin Sodium Sales Market Share by Region (2021-2026) Table 51. Global Enoxaparin Sodium Sales Forecasted by Region (2027-2032) & (M Units) Table 52. Global Enoxaparin Sodium Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 54. North America Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 55. North America Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 56. Europe Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 57. Europe Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 58. Europe Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 59. Asia Pacific Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 60. Asia Pacific Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 61. Asia Pacific Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 62. South America, Middle East and Africa Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 63. South America, Middle East and Africa Enoxaparin Sodium Sales by Country (2021-2026) & (M Units) Table 64. South America, Middle East and Africa Enoxaparin Sodium Sales by Country (2027-2032) & (M Units) Table 65. Global Enoxaparin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Enoxaparin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Enoxaparin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Enoxaparin Sodium Revenue Market Share by Region (2021-2026) Table 69. Global Enoxaparin Sodium Revenue Market Share by Region (2027-2032) Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sanofi Enoxaparin Sodium Product Portfolio Table 74. Sanofi Recent Development Table 75. Teva Company Information Table 76. Teva Business Overview Table 77. Teva Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Teva Enoxaparin Sodium Product Portfolio Table 79. Teva Recent Development Table 80. Techdow (Hepalink) Company Information Table 81. Techdow (Hepalink) Business Overview Table 82. Techdow (Hepalink) Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Techdow (Hepalink) Enoxaparin Sodium Product Portfolio Table 84. Techdow (Hepalink) Recent Development Table 85. Fresenius Kabi Company Information Table 86. Fresenius Kabi Business Overview Table 87. Fresenius Kabi Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Fresenius Kabi Enoxaparin Sodium Product Portfolio Table 89. Fresenius Kabi Recent Development Table 90. Rovi Company Information Table 91. Rovi Business Overview Table 92. Rovi Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Rovi Enoxaparin Sodium Product Portfolio Table 94. Rovi Recent Development Table 95. Amphastar Company Information Table 96. Amphastar Business Overview Table 97. Amphastar Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Amphastar Enoxaparin Sodium Product Portfolio Table 99. Amphastar Recent Development Table 100. Nanjing King-friend Company Information Table 101. Nanjing King-friend Business Overview Table 102. Nanjing King-friend Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Nanjing King-friend Enoxaparin Sodium Product Portfolio Table 104. Nanjing King-friend Recent Development Table 105. Sandoz Company Information Table 106. Sandoz Business Overview Table 107. Sandoz Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Sandoz Enoxaparin Sodium Product Portfolio Table 109. Sandoz Recent Development Table 110. Apotex Company Information Table 111. Apotex Business Overview Table 112. Apotex Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Apotex Enoxaparin Sodium Product Portfolio Table 114. Apotex Recent Development Table 115. Hangzhou Jiuyuan Gene Engineering Company Information Table 116. Hangzhou Jiuyuan Gene Engineering Business Overview Table 117. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio Table 119. Hangzhou Jiuyuan Gene Engineering Recent Development Table 120. Cipla Company Information Table 121. Cipla Business Overview Table 122. Cipla Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Cipla Enoxaparin Sodium Product Portfolio Table 124. Cipla Recent Development Table 125. Taj Pharma Company Information Table 126. Taj Pharma Business Overview Table 127. Taj Pharma Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Taj Pharma Enoxaparin Sodium Product Portfolio Table 129. Taj Pharma Recent Development Table 130. Chengdu Baiyu Pharmaceutical Company Information Table 131. Chengdu Baiyu Pharmaceutical Business Overview Table 132. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio Table 134. Chengdu Baiyu Pharmaceutical Recent Development Table 135. Suzhou Erye Pharmaceutical Company Information Table 136. Suzhou Erye Pharmaceutical Business Overview Table 137. Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio Table 139. Suzhou Erye Pharmaceutical Recent Development Table 140. Changzhou Qianhong Bio-pharma Company Information Table 141. Changzhou Qianhong Bio-pharma Business Overview Table 142. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio Table 144. Changzhou Qianhong Bio-pharma Recent Development Table 145. Hebei Changshan Biochemical Pharmaceutical Company Information Table 146. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 147. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio Table 149. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 150. Beijing SL Pharmaceutical Company Information Table 151. Beijing SL Pharmaceutical Business Overview Table 152. Beijing SL Pharmaceutical Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio Table 154. Beijing SL Pharmaceutical Recent Development Table 155. Huadong Medicine Company Information Table 156. Huadong Medicine Business Overview Table 157. Huadong Medicine Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Huadong Medicine Enoxaparin Sodium Product Portfolio Table 159. Huadong Medicine Recent Development Table 160. Bharat Serums Company Information Table 161. Bharat Serums Business Overview Table 162. Bharat Serums Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Bharat Serums Enoxaparin Sodium Product Portfolio Table 164. Bharat Serums Recent Development Table 165. INTAS Company Information Table 166. INTAS Business Overview Table 167. INTAS Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. INTAS Enoxaparin Sodium Product Portfolio Table 169. INTAS Recent Development Table 170. LUPIN Company Information Table 171. LUPIN Business Overview Table 172. LUPIN Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. LUPIN Enoxaparin Sodium Product Portfolio Table 174. LUPIN Recent Development Table 175. Troikaa Pharmaceuticals Company Information Table 176. Troikaa Pharmaceuticals Business Overview Table 177. Troikaa Pharmaceuticals Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio Table 179. Troikaa Pharmaceuticals Recent Development Table 180. Aristopharma Company Information Table 181. Aristopharma Business Overview Table 182. Aristopharma Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Aristopharma Enoxaparin Sodium Product Portfolio Table 184. Aristopharma Recent Development Table 185. Fosun Pharma Company Information Table 186. Fosun Pharma Business Overview Table 187. Fosun Pharma Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 188. Fosun Pharma Enoxaparin Sodium Product Portfolio Table 189. Fosun Pharma Recent Development Table 190. SciencePharma Company Information Table 191. SciencePharma Business Overview Table 192. SciencePharma Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 193. SciencePharma Enoxaparin Sodium Product Portfolio Table 194. SciencePharma Recent Development Table 195. PISA Company Information Table 196. PISA Business Overview Table 197. PISA Enoxaparin Sodium Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 198. PISA Enoxaparin Sodium Product Portfolio Table 199. PISA Recent Development Table 200. Key Raw Materials Table 201. Raw Materials Key Suppliers Table 202. Enoxaparin Sodium Distributors List Table 203. Enoxaparin Sodium Customers List Table 204. Research Programs/Design for This Report Table 205. Authors List of This Report Table 206. Secondary Sources Table 207. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Product Image Figure 2. Global Enoxaparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Sales (2021-2032) & (M Units) Figure 5. Global Enoxaparin Sodium Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 20 mg/0.2mL Image Figure 9. 30 mg/0.3mL Image Figure 10. 40 mg/0.4mL Image Figure 11. 60 mg/0.6mL Image Figure 12. 80 mg/0.8mL Image Figure 13. 100 mg/1mL Image Figure 14. 120 mg/0.8mL Image Figure 15. 150 mg/1mL Image Figure 16. 300mg/3mL Image Figure 17. Global Enoxaparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 18. Global Enoxaparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Enoxaparin Sodium Sales Market Share by Type (2021-2032) Figure 20. Global Enoxaparin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 21. Global Enoxaparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Enoxaparin Sodium Revenue Market Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Clinic Image Figure 25. Others Image Figure 26. Global Enoxaparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 27. Global Enoxaparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Enoxaparin Sodium Sales Market Share by Application (2021-2032) Figure 29. Global Enoxaparin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 30. Global Enoxaparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Enoxaparin Sodium Revenue Market Share by Application (2021-2032) Figure 32. North America Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 33. North America Enoxaparin Sodium Sales Market Share by Country (2021-2032) Figure 34. U.S. Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Canada Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Mexico Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Europe Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Europe Enoxaparin Sodium Sales Market Share by Country (2021-2032) Figure 39. Germany Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 40. France Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 41. U.K. Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Italy Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Netherlands Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Asia Pacific Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Asia Pacific Enoxaparin Sodium Sales Market Share by Country (2021-2032) Figure 46. China Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 47. Japan Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South Korea Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 49. Southeast Asia Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 50. India Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 51. Australia Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 52. South America, Middle East and Africa Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 53. South America, Middle East and Africa Enoxaparin Sodium Sales Market Share by Country (2021-2032) Figure 54. Brazil Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 55. South Africa Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Saudi Arabia Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Turkey Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 58. Argentina Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 59. UAE Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 60. Egypt Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 61. Chile Enoxaparin Sodium Sales and Growth Rate (2021-2032) & (M Units) Figure 62. Global Enoxaparin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Enoxaparin Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Figure 65. North America Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Figure 67. Europe Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Enoxaparin Sodium Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Enoxaparin Sodium Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Enoxaparin Sodium Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 300mg/3mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Teva
  • Techdow (Hepalink)
  • Fresenius Kabi
  • Rovi
  • Amphastar
  • Nanjing King-friend
  • Sandoz
  • Apotex
  • Hangzhou Jiuyuan Gene Engineering
  • Cipla
  • Taj Pharma
  • Chengdu Baiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Changzhou Qianhong Bio-pharma
  • Hebei Changshan Biochemical Pharmaceutical
  • Beijing SL Pharmaceutical
  • Huadong Medicine
  • Bharat Serums
  • INTAS
  • LUPIN
  • Troikaa Pharmaceuticals
  • Aristopharma
  • Fosun Pharma
  • SciencePharma
  • PISA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enoxaparin Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enoxaparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Enoxaparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Enoxaparin Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Enoxaparin Sodium Market Dynamics
  1. 2.1 Enoxaparin Sodium Industry Trends
  2. 2.2 Enoxaparin Sodium Industry Drivers
  3. 2.3 Enoxaparin Sodium Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Industry Restraints
3 Enoxaparin Sodium Market by Manufacturers
  1. 3.1 Global Enoxaparin Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Enoxaparin Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Enoxaparin Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enoxaparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Enoxaparin Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Enoxaparin Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enoxaparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enoxaparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enoxaparin Sodium Tier 1, Tier 2, and Tier 3
4 Enoxaparin Sodium Market by Type
  1. 4.1 Enoxaparin Sodium Type Introduction
  2. 4.1.1 20 mg/0.2mL
  3. 4.1.2 30 mg/0.3mL
  4. 4.1.3 40 mg/0.4mL
  5. 4.1.4 60 mg/0.6mL
  6. 4.1.5 80 mg/0.8mL
  7. 4.1.6 100 mg/1mL
  8. 4.1.7 120 mg/0.8mL
  9. 4.1.8 150 mg/1mL
  10. 4.1.9 300mg/3mL
  11. 4.2 Global Enoxaparin Sodium Sales by Type
  12. 4.2.1 Global Enoxaparin Sodium Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Enoxaparin Sodium Sales by Type (2021-2032)
  14. 4.2.3 Global Enoxaparin Sodium Sales Market Share by Type (2021-2032)
  15. 4.3 Global Enoxaparin Sodium Revenue by Type
  16. 4.3.1 Global Enoxaparin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Enoxaparin Sodium Revenue by Type (2021-2032)
  18. 4.3.3 Global Enoxaparin Sodium Revenue Market Share by Type (2021-2032)
5 Enoxaparin Sodium Market by Application
  1. 5.1 Enoxaparin Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Sales by Application
  6. 5.2.1 Global Enoxaparin Sodium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Sales by Application (2021-2032)
  8. 5.2.3 Global Enoxaparin Sodium Sales Market Share by Application (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Revenue by Application
  10. 5.3.1 Global Enoxaparin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Enoxaparin Sodium Revenue by Application (2021-2032)
  12. 5.3.3 Global Enoxaparin Sodium Revenue Market Share by Application (2021-2032)
6 Global Enoxaparin Sodium Sales by Region
  1. 6.1 Global Enoxaparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enoxaparin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Enoxaparin Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Enoxaparin Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Enoxaparin Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Enoxaparin Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Enoxaparin Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Enoxaparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Enoxaparin Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Enoxaparin Sodium Revenue by Region
  1. 7.1 Global Enoxaparin Sodium Revenue by Region
  2. 7.1.1 Global Enoxaparin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Enoxaparin Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Enoxaparin Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Enoxaparin Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Enoxaparin Sodium Revenue (2021-2032)
  8. 7.2.2 North America Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Enoxaparin Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Enoxaparin Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Enoxaparin Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Enoxaparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Enoxaparin Sodium Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Enoxaparin Sodium Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Techdow (Hepalink)
  14. 8.3.1 Techdow (Hepalink) Company Information
  15. 8.3.2 Techdow (Hepalink) Business Overview
  16. 8.3.3 Techdow (Hepalink) Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Techdow (Hepalink) Enoxaparin Sodium Product Portfolio
  18. 8.3.5 Techdow (Hepalink) Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Enoxaparin Sodium Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Rovi
  26. 8.5.1 Rovi Company Information
  27. 8.5.2 Rovi Business Overview
  28. 8.5.3 Rovi Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Rovi Enoxaparin Sodium Product Portfolio
  30. 8.5.5 Rovi Recent Developments
  31. 8.6 Amphastar
  32. 8.6.1 Amphastar Company Information
  33. 8.6.2 Amphastar Business Overview
  34. 8.6.3 Amphastar Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Amphastar Enoxaparin Sodium Product Portfolio
  36. 8.6.5 Amphastar Recent Developments
  37. 8.7 Nanjing King-friend
  38. 8.7.1 Nanjing King-friend Company Information
  39. 8.7.2 Nanjing King-friend Business Overview
  40. 8.7.3 Nanjing King-friend Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing King-friend Enoxaparin Sodium Product Portfolio
  42. 8.7.5 Nanjing King-friend Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Enoxaparin Sodium Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
  49. 8.9 Apotex
  50. 8.9.1 Apotex Company Information
  51. 8.9.2 Apotex Business Overview
  52. 8.9.3 Apotex Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Apotex Enoxaparin Sodium Product Portfolio
  54. 8.9.5 Apotex Recent Developments
  55. 8.10 Hangzhou Jiuyuan Gene Engineering
  56. 8.10.1 Hangzhou Jiuyuan Gene Engineering Company Information
  57. 8.10.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  58. 8.10.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Product Portfolio
  60. 8.10.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Enoxaparin Sodium Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Taj Pharma
  68. 8.12.1 Taj Pharma Company Information
  69. 8.12.2 Taj Pharma Business Overview
  70. 8.12.3 Taj Pharma Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Taj Pharma Enoxaparin Sodium Product Portfolio
  72. 8.12.5 Taj Pharma Recent Developments
  73. 8.13 Chengdu Baiyu Pharmaceutical
  74. 8.13.1 Chengdu Baiyu Pharmaceutical Company Information
  75. 8.13.2 Chengdu Baiyu Pharmaceutical Business Overview
  76. 8.13.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Product Portfolio
  78. 8.13.5 Chengdu Baiyu Pharmaceutical Recent Developments
  79. 8.14 Suzhou Erye Pharmaceutical
  80. 8.14.1 Suzhou Erye Pharmaceutical Company Information
  81. 8.14.2 Suzhou Erye Pharmaceutical Business Overview
  82. 8.14.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Product Portfolio
  84. 8.14.5 Suzhou Erye Pharmaceutical Recent Developments
  85. 8.15 Changzhou Qianhong Bio-pharma
  86. 8.15.1 Changzhou Qianhong Bio-pharma Company Information
  87. 8.15.2 Changzhou Qianhong Bio-pharma Business Overview
  88. 8.15.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Product Portfolio
  90. 8.15.5 Changzhou Qianhong Bio-pharma Recent Developments
  91. 8.16 Hebei Changshan Biochemical Pharmaceutical
  92. 8.16.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  93. 8.16.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  94. 8.16.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Product Portfolio
  96. 8.16.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  97. 8.17 Beijing SL Pharmaceutical
  98. 8.17.1 Beijing SL Pharmaceutical Company Information
  99. 8.17.2 Beijing SL Pharmaceutical Business Overview
  100. 8.17.3 Beijing SL Pharmaceutical Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Beijing SL Pharmaceutical Enoxaparin Sodium Product Portfolio
  102. 8.17.5 Beijing SL Pharmaceutical Recent Developments
  103. 8.18 Huadong Medicine
  104. 8.18.1 Huadong Medicine Company Information
  105. 8.18.2 Huadong Medicine Business Overview
  106. 8.18.3 Huadong Medicine Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Huadong Medicine Enoxaparin Sodium Product Portfolio
  108. 8.18.5 Huadong Medicine Recent Developments
  109. 8.19 Bharat Serums
  110. 8.19.1 Bharat Serums Company Information
  111. 8.19.2 Bharat Serums Business Overview
  112. 8.19.3 Bharat Serums Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bharat Serums Enoxaparin Sodium Product Portfolio
  114. 8.19.5 Bharat Serums Recent Developments
  115. 8.20 INTAS
  116. 8.20.1 INTAS Company Information
  117. 8.20.2 INTAS Business Overview
  118. 8.20.3 INTAS Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 INTAS Enoxaparin Sodium Product Portfolio
  120. 8.20.5 INTAS Recent Developments
  121. 8.21 LUPIN
  122. 8.21.1 LUPIN Company Information
  123. 8.21.2 LUPIN Business Overview
  124. 8.21.3 LUPIN Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 LUPIN Enoxaparin Sodium Product Portfolio
  126. 8.21.5 LUPIN Recent Developments
  127. 8.22 Troikaa Pharmaceuticals
  128. 8.22.1 Troikaa Pharmaceuticals Company Information
  129. 8.22.2 Troikaa Pharmaceuticals Business Overview
  130. 8.22.3 Troikaa Pharmaceuticals Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Troikaa Pharmaceuticals Enoxaparin Sodium Product Portfolio
  132. 8.22.5 Troikaa Pharmaceuticals Recent Developments
  133. 8.23 Aristopharma
  134. 8.23.1 Aristopharma Company Information
  135. 8.23.2 Aristopharma Business Overview
  136. 8.23.3 Aristopharma Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Aristopharma Enoxaparin Sodium Product Portfolio
  138. 8.23.5 Aristopharma Recent Developments
  139. 8.24 Fosun Pharma
  140. 8.24.1 Fosun Pharma Company Information
  141. 8.24.2 Fosun Pharma Business Overview
  142. 8.24.3 Fosun Pharma Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Fosun Pharma Enoxaparin Sodium Product Portfolio
  144. 8.24.5 Fosun Pharma Recent Developments
  145. 8.25 SciencePharma
  146. 8.25.1 SciencePharma Company Information
  147. 8.25.2 SciencePharma Business Overview
  148. 8.25.3 SciencePharma Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 SciencePharma Enoxaparin Sodium Product Portfolio
  150. 8.25.5 SciencePharma Recent Developments
  151. 8.26 PISA
  152. 8.26.1 PISA Company Information
  153. 8.26.2 PISA Business Overview
  154. 8.26.3 PISA Enoxaparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 PISA Enoxaparin Sodium Product Portfolio
  156. 8.26.5 PISA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enoxaparin Sodium Value Chain Analysis
  2. 9.1.1 Enoxaparin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enoxaparin Sodium Production Mode & Process
  6. 9.2 Enoxaparin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enoxaparin Sodium Distributors
  9. 9.2.3 Enoxaparin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst